Gene · 722
Papers2,921
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
601 to 620 of 2,921
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Expression Profile of mRNAs and miRNAs Related to the Oxidative-Stress Phenomenon in the Ishikawa Cell Line Treated Either Cisplatin or Salinomycin. | Biomedicines | 2022 | 35625926 | PubTator, text mining | PubMed |
| Bioengineering Approaches for Delivering Growth Factors: A Focus on Bone and Cartilage Regeneration. | Bioengineering (Basel) | 2022 | 35621501 | PubTator, text mining | PubMed |
| Complement Factor I Variants in Complement-Mediated Renal Diseases. | Front Immunol | 2022 | 35619721 | PubTator, text mining | PubMed |
| Total Plasma Protein S Is a Prothrombotic Marker in People Living With HIV. | J Acquir Immune Defic Syndr | 2022 | 35616596 | PubTator, text mining | PubMed |
| Chitosan-Based Biomaterial Scaffolds for the Repair of Infected Bone Defects. | Front Bioeng Biotechnol | 2022 | 35600891 | PubTator, text mining | PubMed |
| Protein-coated nanostructured surfaces affect the adhesion of Escherichia coli. | Nanoscale | 2022 | 35579413 | PubTator, text mining | PubMed |
| Complement System and Alarmin HMGB1 Crosstalk: For Better or Worse. | Front Immunol | 2022 | 35572583 | PubTator, text mining | PubMed |
| Systematic Review and Meta-Analysis of Mass Spectrometry Proteomics Applied to Human Peripheral Fluids to Assess Potential Biomarkers of Schizophrenia. | Int J Mol Sci | 2022 | 35563307 | PubTator, text mining | PubMed |
| Quantitative proteomics reveals specific protein regulation of severe hypospadias. | Transl Androl Urol | 2022 | 35558266 | PubTator, text mining | PubMed |
| The Hidden Side of Complement Regulator C4BP: Dissection and Evaluation of Its Immunomodulatory Activity. | Front Immunol | 2022 | 35547734 | PubTator, text mining | PubMed |
| Novel Markers for Liquid Biopsies in Cancer Management: Circulating Platelets and Extracellular Vesicles. | Mol Cancer Ther | 2022 | 35545008 | PubTator, text mining | PubMed |
| The Host-Pathogen Interactions and Epicellular Lifestyle of Neisseria meningitidis. | Front Cell Infect Microbiol | 2022 | 35531336 | PubTator, text mining | PubMed |
| The Significance of Tumor Microenvironment Score for Breast Cancer Patients. | Biomed Res Int | 2022 | 35528180 | PubTator, text mining | PubMed |
| Discovering Common Pathophysiological Processes between COVID-19 and Cystic Fibrosis by Differential Gene Expression Pattern Analysis. | Biomed Res Int | 2022 | 35528173 | PubTator, text mining | PubMed |
| Interval-Based Secretomics Unravels Acute-Phase Response in Hepatocyte Model Systems. | Mol Cell Proteomics | 2022 | 35525403 | PubTator, text mining | PubMed |
| The first laminin G-like domain of protein S is essential for binding and activation of Tyro3 receptor and intracellular signalling. | Biochem Biophys Rep | 2022 | 35518197 | PubTator, text mining | PubMed |
| Diversity in Phenotypes Associated With Host Persistence and Systemic Virulence in Streptococcus sanguinis Strains. | Front Microbiol | 2022 | 35509310 | PubTator, text mining | PubMed |
Analysis of Complement Gene Expression, Clinical Associations, and Biodistribution of Complement Proteins in the Synovium of Early Rheumatoid Arthritis Patients Reveals Unique Pathophysiologic Features. | J Immunol | 2022 | 35500934 | PubTator, text mining | PubMed |
| Evaluation of a Standardized Protocol for Plasma Rich in Growth Factors Obtention in Cats: A Prospective Study. | Front Vet Sci | 2022 | 35498746 | PubTator, text mining | PubMed |
| Balancing selection at the human salivary agglutinin gene (DMBT1) driven by host-microbe interactions. | iScience | 2022 | 35494225 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/722/papers?page=31